IL1R2 and myocardial ischemia: In the study, IL1R2 has been shown to inhibit cardiomyocyte apoptosis during myocardial ischemia-reperfusion injury, suggesting its potential as a therapeutic target for the prevention and treatment of myocardial infarction (53).